You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult liposarcoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

Active, not recruiting
  • Leiomyosarcoma
  • +3 more
  • Taipei, Taiwan
  • +1 more
Dec 27, 2022

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma Trial in

Terminated
Has Results
  • Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma
  • Lille, France
  • +5 more
Dec 31, 2020

Liposarcoma Trial in Worldwide (HDM201, LEE011)

Completed
  • Liposarcoma
  • Toronto, Ontario, Canada
  • +8 more
Dec 6, 2020

Sarcoma, Myxoid/Round Cell Liposarcoma, Synovial Sarcoma Trial in United States (CMB305, atezolizumab)

Terminated
Has Results
  • Sarcoma
  • +6 more
  • CMB305
  • atezolizumab
  • Palo Alto, California
  • +17 more
Jun 26, 2020

Liposarcoma, Leiomyosarcoma Trial in Italy (Trabectedin)

Completed
  • Liposarcoma
  • Leiomyosarcoma
  • Bari, BA, Italy
  • +20 more
Oct 29, 2021

Tumors Trial in United States (letetresgene autoleucel (GSK3377794), Cyclophosphamide, Fludarabine)

Completed
Has Results
  • Neoplasms
  • letetresgene autoleucel (GSK3377794)
  • +2 more
  • Tampa, Florida
  • +5 more
Oct 31, 2022

Engagement Patterns and Participation Trends Among Liposarcoma

Not yet recruiting
  • Liposarcoma
    • San Francisco, California
      Power Life Sciences
    Sep 8, 2023

    Dedifferentiated Liposarcoma Patients in China

    Not yet recruiting
    • Dedifferentiated Liposarcoma
      • Beijing, China
        Beijing Jishuitan hospital
      Oct 30, 2023

      Liposarcoma, Dedifferentiated Trial in Worldwide (BI 907828, Doxorubicin)

      Recruiting
      • Liposarcoma, Dedifferentiated
      • Birmingham, Alabama
      • +131 more
      Feb 2, 2023

      Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

      Active, not recruiting
      • Sarcoma, Soft Tissue
      • Changsha, Hunan, China
        Xiangya Hospital Central South University
      Oct 29, 2023

      Status of Surgical Resection and Histologic Subtype as

      Completed
      • Liposarcoma of Soft Tissue
      • Surgical Procedure, Unspecified
      • Retroperitoneal Liposarcoma resection
      • São Paulo, Brazil
        Hospital das Clínicas da Faculdade de Medicina da Universidade d
      Jun 18, 2022

      Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)

      Active, not recruiting
      • Liposarcoma
      • Metastatic Liposarcoma
      • Boston, Massachusetts
      • +2 more
      Nov 23, 2022

      Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)

      Completed
      Has Results
      • Dedifferentiated Liposarcoma
      • Los Angeles, California
      • +70 more
      Jan 5, 2023

      Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma

      Not yet recruiting
      • Advanced Dedifferentiated Liposarcoma
      • +5 more
      • (no location specified)
      Jan 11, 2023

      Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults Trial in Italy, Spain (epirubicin 60

      Active, not recruiting
      • Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults
      • epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)
      • +5 more
      • Candiolo, TO, Italy
      • +14 more
      Nov 15, 2021

      Sarcoma Trial in United Kingdom (radiotherapy)

      Completed
      • Sarcoma
      • radiotherapy
      • Birmingham, England, United Kingdom
      • +5 more
      Mar 17, 2021

      Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

      Terminated
      • Neoplasms
      • New Haven, Connecticut
      • +20 more
      Jul 5, 2023

      Dedifferentiated Liposarcoma Trial in Beijing, Shanghai (TQB3616 capsule, TQB3616 )

      Not yet recruiting
      • Dedifferentiated Liposarcoma
      • TQB3616 capsule
      • TQB3616 placebo
      • Beijing, Beijing, China
      • +2 more
      Aug 9, 2022

      Dedifferentiated Liposarcoma, Soft Tissue Sarcoma, Sarcoma,Soft Tissue Trial in United States (Etrumadenant, Zimberelimab)

      Recruiting
      • Dedifferentiated Liposarcoma
      • +6 more
      • Basking Ridge, New Jersey
      • +6 more
      May 23, 2023

      Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma Trial in Worldwide (Surgery, Preoperative chemo)

      Recruiting
      • Retroperitoneal Sarcoma
      • +2 more
      • Surgery
      • Preoperative chemotherapy
      • Woolloongabba, Queensland, Australia
      • +36 more
      Dec 27, 2022

      Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

      Terminated
      • Neoplasms
      • New Haven, Connecticut
      • +20 more
      Sep 15, 2023

      Sarcoma, Dedifferentiated Liposarcoma Trial in New York (Abemaciclib)

      Active, not recruiting
      • Sarcoma
      • Dedifferentiated Liposarcoma
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Aug 17, 2022

      Leiomyosarcoma, Liposarcoma Trial in New York (ATX-101)

      Recruiting
      • Leiomyosarcoma
      • Liposarcoma
      • New York, New York
        Columbia University Irving Medical Center / NewYork-Presbyterian
      Nov 23, 2022

      Dedifferentiated Liposarcoma Trial in Worldwide (RAIN-32, Trabectedin)

      Active, not recruiting
      • Dedifferentiated Liposarcoma
      • Palo Alto, California
      • +70 more
      Aug 4, 2022